Carrie Williams

About the Author Carrie Williams


A Director at Lamar Advertising is Exercising Options

Today it was reported that a Director at Lamar Advertising (LAMR), Thomas Reifenheiser, exercised options to buy 6,000 LAMR shares at $18.25 a …

The VP Finance & Chief Acctg Offcr of Endocyte is Exercising Options

Today it was reported that the VP Finance & Chief Acctg Offcr of Endocyte (ECYT), Beth Taylor, exercised options to buy 48,854 ECYT …

Oppenheimer Sticks to Its Buy Rating for Ctripcom (CTRP)

In a report released today, Jed Kelly from Oppenheimer maintained a Buy rating on Ctripcom (CTRP). The company’s shares opened today at $26.

The CSO of Endocyte is Exercising Options

Today it was reported that the CSO of Endocyte (ECYT), Philip Low, exercised options to buy 140,214 ECYT shares at $5.52 a share, …

The President & CEO of Endocyte is Exercising Options

Today it was reported that the President & CEO of Endocyte (ECYT), Michael A. Sherman, exercised options to buy 115,559 ECYT shares at …

The EVP of Citizens & Northern Corp (CZNC) is Buying Shares

Today, the EVP of Citizens & Northern Corp (CZNC), Thomas Rudy, bought shares of CZNC for $53.36K.

The VP – Sales of Blonder Tongue Laboratories (BDR) is Selling Shares

Today, the VP – Sales of Blonder Tongue Laboratories (BDR), Jeffrey W. Smith, sold shares of BDR for $7,513.

Roth Capital Thinks Aimmune Therapeutics’ Stock is Going to Recover

In a report released today, Jotin Marango from Roth Capital maintained a Buy rating on Aimmune Therapeutics (AIMT), with a price target of …

The CCO of Centerstate Banks (CSFL) is Buying Shares

Today, the CCO of Centerstate Banks (CSFL), Daniel Bockhorst, bought shares of CSFL for $20.87K.

Cantor Fitzgerald Keeps a Buy Rating on AxoGen (AXGN)

In a report released today, Craig Bijou from Cantor Fitzgerald maintained a Buy rating on AxoGen (AXGN), with a price target of $43. …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts